High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke

Hasan Kara,1 Murat Akinci,1 Selim Degirmenci,1 Aysegul Bayir,1 Ahmet Ak,1 Alaaddin Nayman,2 Ali Unlu,3 Fikret Akyurek,3 Mesut Sivri2 1Department of Emergency Medicine, 2Department of Radiology, 3Department of Biochemistry, Faculty of Medicine, Selçuk University, Konya, Turkey Backgroun...

Full description

Bibliographic Details
Main Authors: Kara H, Akinci M, Degirmenci S, Bayir A, Ak A, Nayman A, Unlu A, Akyurek F, Sivri M
Format: Article
Language:English
Published: Dove Medical Press 2014-08-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/high-sensitivity-c-reactive-protein-lipoprotein-related-phospholipase--peer-reviewed-article-NDT
id doaj-48c219e9c5f54f56b4b34027bdb0fdf0
record_format Article
spelling doaj-48c219e9c5f54f56b4b34027bdb0fdf02020-11-24T21:23:04ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212014-08-012014default1451145717844High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic strokeKara HAkinci MDegirmenci SBayir AAk ANayman AUnlu AAkyurek FSivri M Hasan Kara,1 Murat Akinci,1 Selim Degirmenci,1 Aysegul Bayir,1 Ahmet Ak,1 Alaaddin Nayman,2 Ali Unlu,3 Fikret Akyurek,3 Mesut Sivri2 1Department of Emergency Medicine, 2Department of Radiology, 3Department of Biochemistry, Faculty of Medicine, Selçuk University, Konya, Turkey Background: Serum biomarkers may be useful for early diagnosis of acute ischemic stroke, exclusion of other diseases that may mimic stroke, and prediction of infarct volume. We evaluated serum high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-related phospholipase A2 (Lp-PLA2) in patients who had acute ischemic stroke.Methods: In 200 patients who presented to an emergency service (acute ischemic stroke, 102 patients; control with no stroke, 98 patients), stroke patients were evaluated with the Canadian neurological scale and diffusion-weighted magnetic resonance imaging, and all patients were evaluated with the Glasgow coma scale and their serum hs-CRP level and Lp-PLA2 activity were assessed. The volume of stroke lesions was calculated from magnetic resonance images.Results: Patients who had stroke had higher mean serum hs-CRP level (stroke, 7±6 mg/dL; ­control, mean ± standard deviation 1±1 mg/dL; P≤0.001) and Lp-PLA2 activity (stroke, mean ± standard deviation 113±86 nmol/min/mL; control, mean ± standard deviation 103±50 nmol/min/mL; P≤0.001) than control patients who did not have stroke. The mean hs-CRP level and Lp-PLA2 activity were higher in patients who had greater stroke severity (lower Canadian neurological scale score) and were higher in patients who had larger volume strokes. Conclusion: Higher hs-CRP level and Lp-PLA2 activity are significantly associated with more severe neurologic impairment and larger infarct size in patients who have acute ischemic stroke. These biomarkers may be useful for rapid diagnosis and prediction of ischemic tissue volume in the early stage of ischemic stroke. These findings may be important for health care facilities that have limited access to emergency computed tomography scanning for the diagnosis of stroke. Keywords: cerebrovascular accident, atherosclerosis, inflammation, biomarkerhttp://www.dovepress.com/high-sensitivity-c-reactive-protein-lipoprotein-related-phospholipase--peer-reviewed-article-NDT
collection DOAJ
language English
format Article
sources DOAJ
author Kara H
Akinci M
Degirmenci S
Bayir A
Ak A
Nayman A
Unlu A
Akyurek F
Sivri M
spellingShingle Kara H
Akinci M
Degirmenci S
Bayir A
Ak A
Nayman A
Unlu A
Akyurek F
Sivri M
High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
Neuropsychiatric Disease and Treatment
author_facet Kara H
Akinci M
Degirmenci S
Bayir A
Ak A
Nayman A
Unlu A
Akyurek F
Sivri M
author_sort Kara H
title High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
title_short High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
title_full High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
title_fullStr High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
title_full_unstemmed High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
title_sort high-sensitivity c-reactive protein, lipoprotein-related phospholipase a2, and acute ischemic stroke
publisher Dove Medical Press
series Neuropsychiatric Disease and Treatment
issn 1178-2021
publishDate 2014-08-01
description Hasan Kara,1 Murat Akinci,1 Selim Degirmenci,1 Aysegul Bayir,1 Ahmet Ak,1 Alaaddin Nayman,2 Ali Unlu,3 Fikret Akyurek,3 Mesut Sivri2 1Department of Emergency Medicine, 2Department of Radiology, 3Department of Biochemistry, Faculty of Medicine, Selçuk University, Konya, Turkey Background: Serum biomarkers may be useful for early diagnosis of acute ischemic stroke, exclusion of other diseases that may mimic stroke, and prediction of infarct volume. We evaluated serum high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-related phospholipase A2 (Lp-PLA2) in patients who had acute ischemic stroke.Methods: In 200 patients who presented to an emergency service (acute ischemic stroke, 102 patients; control with no stroke, 98 patients), stroke patients were evaluated with the Canadian neurological scale and diffusion-weighted magnetic resonance imaging, and all patients were evaluated with the Glasgow coma scale and their serum hs-CRP level and Lp-PLA2 activity were assessed. The volume of stroke lesions was calculated from magnetic resonance images.Results: Patients who had stroke had higher mean serum hs-CRP level (stroke, 7±6 mg/dL; ­control, mean ± standard deviation 1±1 mg/dL; P≤0.001) and Lp-PLA2 activity (stroke, mean ± standard deviation 113±86 nmol/min/mL; control, mean ± standard deviation 103±50 nmol/min/mL; P≤0.001) than control patients who did not have stroke. The mean hs-CRP level and Lp-PLA2 activity were higher in patients who had greater stroke severity (lower Canadian neurological scale score) and were higher in patients who had larger volume strokes. Conclusion: Higher hs-CRP level and Lp-PLA2 activity are significantly associated with more severe neurologic impairment and larger infarct size in patients who have acute ischemic stroke. These biomarkers may be useful for rapid diagnosis and prediction of ischemic tissue volume in the early stage of ischemic stroke. These findings may be important for health care facilities that have limited access to emergency computed tomography scanning for the diagnosis of stroke. Keywords: cerebrovascular accident, atherosclerosis, inflammation, biomarker
url http://www.dovepress.com/high-sensitivity-c-reactive-protein-lipoprotein-related-phospholipase--peer-reviewed-article-NDT
work_keys_str_mv AT karah highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT akincim highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT degirmencis highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT bayira highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT aka highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT naymana highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT unlua highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT akyurekf highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
AT sivrim highsensitivitycreactiveproteinlipoproteinrelatedphospholipasea2andacuteischemicstroke
_version_ 1716726899700400128